Clinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy.

NCT01272310 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
36
Enrollment
OTHER_GOV
Sponsor class

Conditions

Interventions

Sponsor

Sheba Medical Center